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Getting Rid of Rotavirus
On 12 December 1997, the FDA's Vaccine
and Related Biologicals Products Advisory
Committee unanimously concluded that
RotaShield, the first vaccine for rotavirus-
a highly contagious disease that causes life-
threatening diarrhea in young children-is
safe and effective, and recommended
licensing.
In the United States alone, rotavirus
causes 3 million cases ofchildhood diarrhea,
resulting in 500,000 doctor visits, 100,000
hospitalizations, and up to 100 deaths annu-
ally. Direct costs of the disease run to as
much as $400 million and indirect costs
(such as lostwork time for parents) total $1.4
billion. Worldwide, rotavirus kills 873,000
children each year, largely in underdeveloped
countries. The vaccine is intended to be
administered in three doses at 2, 4, and 6
months of age when children receive their
polio vaccine.
The RotaShield vaccine was created and
patented by virologist and physician Albert
Kapikian and his colleagues at the National
Institute ofAllergy and Infectious Diseases in
Bethesda, Maryland. Kapikian, head of the
epidemiology section of the Laboratory of
Infectious Diseases, has devoted nearly 25
years to studying rotavirus. "It's exciting and
gratifying as a physician to see that most
babies can be protected from severe diarrhea
with a product developed in our laboratory,"
he says.
Australian virologists discovered rotavirus
in 1973. Later, several epidemiological stud-
ies proved that rotavirus was the most impor-
tant agent involved in infantile diarrhea
worldwide. Kapikian's ingenuity and perse-
verance helped overcome obstacles in creat-
ing the vaccine. For instance, human
rotavirus resisted growth in cell cultures,
whereas simian rotavirus grew well. The
researchers worked to determine whether an
animal rotavirus could protect humans,
much in the same way that Edward Jenner
determined 200 years ago that vaccinating
people with cowpox could prevent smallpox.
The final vaccine contains a weakened form
of rotavirus obtained from rhesus monkeys,
bioengineered with three genes from human
rotavirus. This combination proved most
effective at protecting people against the four
most prevalent clinical strains ofrotavirus.
The vaccine was tested successfully in
numerous clinical trials. Among 2,000
infants in Venezuela, the vaccine reduced
severe diarrheal illness by 88% and dehydra-
tion by 75%, and decreased hospitalizations
Last of a dying breed? A new vaccine expected to be approved by the FDA may mean the end of
rotavirus outbreaks.
by 70%. This study, reported in the 23
October 1997 issue of the New England
JournalofMedicine, was the largest and most
successful trial ofthe vaccine in a developing
country. A multi-center trial conducted in
the United States of 1,200 children showed
that the vaccine protected 80% of the chil-
dren against severe diarrhea and 100%
against dehydration, as described in the
January 1996 issue of Pediatrics. Another
study, which appeared in the 25 October
1997 issue of Lancet, concluded that when
tested on 2,400 Finnish children the vaccine
reduced severe diarrhea by 91%, clinic visits
for dehydration by 97%, and hospitalizations
by 100%. In the latest study, published in
the October 1997 issue of the Journal of
Pediatrics, the vaccine prevented 69% of
severe cases ofdiarrhea on American Indian
reservations, where incidence rates of
rotavirus disease run higher than for the gen-
eral population. "The routine use ofthis vac-
cine could save lives and prevent illness," says
Mathuram Santosham, director ofthe Johns
Hopkins Center for American Indian and
Alaskan Native Health in Baltimore,
Maryland. In all clinical tests, the vaccinewas
safe andwell-tolerated.
About 90% of all children are infected
by rotavirus by age three regardless of
hygienic conditions. Diarrhea is considered a
normal part of childhood, and few hear
about the small number ofchildren who die
yearly from rotavirus. Although a current
television advertisement for a bathroom
cleaner mentions that it kills rotavirus, in
reality "parents in the U.S. don't know that
rotavirus is a problem," says senior clinical
scientist Michael Pastorino ofWyeth-Ayerst
Research in Radnor, Pennsylvania, a division
of the company seeking licensure for the
RotaShield vaccine. Both parents and physi-
cians need to be educated about the new
vaccine.
Wyeth-Ayerst is seeking a universal rec-
ommendation that all children be vaccinated
for rotavirus from the Advisory Committee
for Immunization Practices at the CDC,
which sets the schedule ofchildhood immu-
nizations.
Stockpiling Safety?
By spring, the Nuclear Regulatory
Commission (NRC) is expected to act, once
again, on the 15-year-old issue ofwhether it
makes sense for states to consider stockpiling
thousands oftablets ofpotassium iodide (KI)
near nuclear power plants in case ofan emer-
gency. No one disputes that KI, a benign
substance longapproved for over-the-counter
use, is an effective thyroid-blocking agent.
And no one is arguing that the cost ofKI is
prohibitive. A 130-mg tablet costs $.07; sup-
plying all residents within five miles ofone of
the United States' 107 operating nuclear
reactors would cost as little as $200,000
(although distributing and disposing of the
supply would add costs). Few even question
the safety ofthe tablets. The issue is whether
having KI on hand would make some resi-
dents trust their fate to a pill rather than to
evacuation.
Many states, as well as the nudear indus-
try, believe evacuation should be the first line
of protective action in a nuclear emergency.
A 128 Volume 106, Number 3, March 1998 * Environmental Health PerspectivesForum
KI isn't a "silver bullet," says Steve
Unglesbee, a spokesman for the Nuclear
Energy Institute in Washington, DC,
because it can create a false sense ofsecurity
as well as "ambiguity through choice."
Unglesbee likes to quote an April 1997
Chicago Sun-Times editorial that argued
against stockpiling: "The idea is akin to
putting a dab ofsunblock on your nose at
the beach; you may end up with a protected
prow, but the rest of your body will be
scorched."
But supporters ofstockpiling, including
the American Thyroid Association, contend
that it would be negligent of the industry
and ofstate and federal governments not to
endorse what-they call a simple and cheap
insurance policy. "I compare it to lifeboats
and life jackets on a ferry," says Peter Crane,
astaffattorney for the NRC and along-time
advocate for the tablets' use. "It's better to be
evacuated in alifeboat, but also helps to have
on alifejacket."
The tablet works by saturating the thy-
roid with iodide, which the organ needs to
make hormones needed by the nervous sys-
tem and brain. A saturated thyroid will not,
therefore, absorb cancer-promoting radioac-
tive iodide that may escape into the air from
a nuclear power plant's containment facility
during a nuclear accident. Crane has been
leading the effort to stockpile KI as a private
citizen since 1989. He says his position
comes from experience; Crane wasdiagnosed
with thyroid cancer at age 26, more than 20
years after having his tonsils irradiated as a
child in a Chicago hospital. He has battled
the disease, which kills about 1,000 U.S. citi-
zens annually, on andofffordecades.
In 1989, when the NRC refused to
change its opinion not to require KI stock-
piling, Crane filed a professional opinion
challenging that action. That was three years
after the Chernobyl nuclear power plant
accident, which resulted in about 900 cases
of thyroid cancer, leaving many Soviet chil-
drenwith the "Belarussian necklace," asurgi-
cal scar that goes from ear to ear, says Crane.
But in Poland, upwind ofthe accident, chil-
dren were given KI pills, and there has been
no increase in thyroid cancer. Also, in 1989
the World Health Organization recom-
mended preventive distribution ofKI, and,
to date, France and Switzerland have distrib-
uted itwidely.
But with one-fourth ofthe world's reac-
tors, the United States has taken a conserva-
tive attitude. Despite a federal recommenda-
tion following the Three Mile Island acci-
dent in 1979 to stockpile KI, the NRC did
not endorse the recommendation in 1985,
and deadlocked on the issue again in 1994
after Crane urged reconsideration. One sur-
vey considered by NRC commissioners
showed that 33 of 43 responding states
opposed stockpiling, in part because they
wouldhave to develop plans to distribute the
pills.
Nevertheless, in October 1996 the feder-
al government agreed to buy KI for anystate
that wanted it. Additionally, plans were
made to stockpile KI in 27 metropolitan
areas and three national stockpiles. To date,
three city stockpiles exist but plans to move
themedicine to accident sites do not.
NowCranewants theNRC tochange its
language to saystockpiling is "reasonable and
prudent" and that states should consider it.
His petition was published in the Federal
Register in December for public comment
and is expected to be voted on by the NRC
after February. Unglesbee says the industry
will oppose the measure, as it always has. He
says that requiring states to consider KI con-
stitutes "an unfunded federal mandate" on
states that have already decided that KI pills
"workagainst moreeffectiveevacuation."
But notall states feel thatway. Tennessee
and Alabama already stockpile KI at emer-
gency centers, and in December, Maine's
Medical insurance? A current debate considers whether stockpiling
potassium iodide near nuclear reactors offers a safeguard or a false
sense ofsecurity.
radiation advisory com-
mittee recommended
stockpiling. Their en-
dorsement came after
strong testimony that
portions of the evacua-
tion plan for the area
surrounding the Maine
Yankee nuclear reactor
in Wiscasset, Maine,
failed during a test. This
reactor, the state's only
nuclear plant, has since
beendosed.
Crane feels that the
NRC will eventually
endorse stockpiling. "It's
a matter ofpeople find-
ing out about it just as
they did in Maine," he says. And what ifthe
NRC votes his petition down? Well, he says,
he can always askforajudicial review.
Gamma Groceries
Highly publicized incidents last year, such as
the recall by Hudson Foods, a Nebraska
meat processor, of millions of pounds of
hamburger contaminated with the potential-
ly deadly bacteria Escherichia coli 0157:H7,
have made food safety a major concern in
the United States. According to the Council
for Agricultural Science and Technology, a
nonprofit organization composed of 30 sci-
entific societies, harmful bacteria carried in
food can cause as many as 9,000 deaths
annually.
In December, the FDAapproved the use
ofionizing radiation to kill harmful microor-
ganisms in red meat as one more tool to pro-
tect the food supply. (The federal govern-
ment hadpreviouslyapproved irradiation for
poultry and fresh fruits and vegetables.) The
move, which allows but does not require
meat processors to irradiate meat, pleased
food scientists and public health officials but
worried some public interest and activist
groups.
Aprime irradiation target is ground beef,
which can be laden with pathogens when
contaminated carcasses are ground to make
hamburger, says Michael Doyle, director of
the Center for Food Safety and Quality
Enhancement at theUniversityofGeorgia in
Athens. Irradiating meat is a fairly simple
process in which packaged meat is subjected
to ionizing radiation-either gamma rays
from radioactive materials such as cobalt 60
orcesium 137 orhighenergyelectrons.
Though the U.S. Department of
Agriculture has not drawn up rules to
describe in detail how the process will
work-it's estimated that rule development
will take about a year-food scientists envi-
sion it occurring at the end of the packing
process, just before the meat is shipped from
the plant to retail stores. "It will make meat
at the point ofpurchase at least 90% safer
than it is today," says Curtis Melton, a pro-
fessor of food science at the University of
Tennessee in Knoxville.
Dennis Buege, a professor ofanimal sci-
ence at the University of Wisconsin in
Madison, says irradiation will increase
ground beef's shelf life. "Rather than your
package of ground beef staying in your
refrigerator in good condition for three days,
it may stay in good condition for six days,"
he says. Irradiation may also be particularly
important in nursing homes and other insti-
tutional settings, where foodsafety is amajor
concern because food is prepared for relative-
lylarge numbers ofpeople, says Buege.
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